You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-CBL antibody (ab6077)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-CBL antibody
See all CBL products (19) ...

Description

Rabbit polyclonal to CBL

Tested applications

IHC-P, WB, IP, IHC-Frmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Synthetic peptide: REFVSISSPAHVAT mapping to the carboxy terminal domain of human CBL.

REFVSISSPA HVAT

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: 0.2% Gelatin, PBS

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-CBL antibody(ab6077)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-CBL antibody(ab6077) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab6077 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Participates in signal transduction in hematopoietic cells. Adapter protein that functions as a negative regulator of many signaling pathways that start from receptors at the cell surface. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including PDGFA, EGF and CSF1, and terminates signaling.

Pathway

Protein modification; protein ubiquitination.

Involvement in disease

Defects in CBL are the cause of Noonan syndrome-like disorder (NSL) [MIM:613563]. NSL is a syndrome characterized by a phenotype reminiscent of Noonan syndrome. Clinical features are highly variable, including facial dysmorphism, short neck, developmental delay, hyperextensible joints and thorax abnormalities with widely spaced nipples. The facial features consist of triangular face with hypertelorism, large low-set ears, ptosis, and flat nasal bridge. Some patients manifest cardiac defects.

Sequence similarities

Contains 1 Cbl-PTB (Cbl-type phosphotyrosine-binding) domain.
Contains 1 RING-type zinc finger.
Contains 1 UBA domain.

Domain

The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme.
The N-terminus is composed of the phosphotyrosine binding (PTB) domain, a short linker region and the RING-type zinc finger. The PTB domain, which is also called TKB (tyrosine kinase binding) domain, is composed of three different subdomains: a four-helix bundle (4H), a calcium-binding EF hand and a divergent SH2 domain.

Post-translational
modifications

Phosphorylated on tyrosine residues by EGFR, SYK, FYN and ZAP70 (By similarity). Phosphorylated on tyrosine residues by INSR.

Cellular localization

Cytoplasm.

Target information above from: UniProt accessionP22681 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • 4732447J05Rik antibody
  • C CBL antibody
  • Cas Br M (murine) ecotropic retroviral transforming sequence antibody
  • Cas-Br-M (murine) ecotropic retroviral transforming sequence antibody
  • Casitas B lineage lymphoma proto oncogene antibody
  • Casitas B-lineage lymphoma proto-oncogene antibody
  • CBL 2 antibody
  • cbl antibody
  • CBL_HUMAN antibody
  • CBL2 antibody
  • E3 ubiquitin protein ligase CBL antibody
  • E3 ubiquitin-protein ligase CBL antibody
  • Oncogene CBL2 antibody
  • Proto oncogene c CBL antibody
  • Proto-oncogene c-CBL antibody
  • RGD1561386 antibody
  • RING finger protein 55 antibody
  • RNF55 antibody
  • Signal transduction protein CBL antibody
see all

Anti-CBL antibody images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-CBL antibody(ab6077)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-CBL antibody(ab6077)

Ab6077 staining human normal colon tissue. Staining is localised to cytoplasm.
Left panel: with primary antibody at 2 ug/ml. Right panel: isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus ), at room temperature: sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

References for Anti-CBL antibody (ab6077)

ab6077 has not yet been referenced specifically in any publications.

Publishing research using ab6077? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"